Patent Assignment
Reel/Frame 060476/0712
Assignment of Assignor's Interest
Recorded: 2022-07-11
Pages: 8
Assignee
RUIYI BIOPHARMACEUTICS TECHNOLOGY (SHANGHAI) CO. LTD.
1043 HALEI ROAD, SUITE 502, ZHANGJIANG HI-TECH PARK, SHANGHAI, 201203, CHINA
Covered Property
(1)
Treatment of Disease Responsive to Modulation of Cannabanoid 1(CB1) Receptor Signaling
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 11, 2022
From: RUIYI BIOPHARMACEUTICS TECHNOLOGY (SHANGHAI) CO. LTD.
To: RUIYI, INC.
Reel/Frame 060476/0720 →
Assignment of Assignor's Interest
Jul 11, 2022
From: KRETZ-ROMMEL, ANKE; FERRINI, ROGER
To: RUIYI, INC.
Reel/Frame 060476/0736 →
Change of Name
Jul 11, 2022
From: RUIYI, INC.
To: BIRD ROCK BIO, INC.
Reel/Frame 060631/0872 →
Merger and Change of Name
Aug 12, 2024
From: AQUILA MERGER SUB, INC.; BIRD ROCK BIO, INC.
To: BIRD ROCK BIO SUB, INC.
Reel/Frame 068250/0292 →